RTI Surgical is a global surgical implant company that designs, develops, manufactures and distributes biologic, metal and synthetic implants. Co. designs, manufactures, and distributes surgical implants, instruments, and biologics used in the treatment of conditions affecting the spine caused by degenerative conditions, deformities or traumatic injury. Co.' principle implant offering includes a variety of systems comprised of components such as spine screws and rods, spinal spacers, plates, and various biologics offerings designed to support, improve, or promote spinal fusion. Co. also markets and distributes its implants via relationships with Original Equipment Manufacturer distributors. The RTIX stock yearly return is shown above.
The yearly return on the RTIX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the RTIX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|